EntryPoint Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,021
| Closed | -$434K | – | 886 |
|
|
2024
Q4 | $434K | Buy |
23,021
+7,062
| +44% | +$133K | 0.18% | 166 |
|
|
2024
Q3 | $240K | Buy |
+15,959
| New | +$240K | 0.14% | 360 |
|
|
2024
Q2 | – | Sell |
-8,335
| Closed | -$244K | – | 1440 |
|
|
2024
Q1 | $244K | Buy |
8,335
+2,629
| +46% | +$76.8K | 0.22% | 55 |
|
|
2023
Q4 | $193K | Buy |
+5,706
| New | +$193K | 0.18% | 106 |
|